Background: Missing data are common in end-of-life care studies, but there is still relatively little exploration of which is the best method to deal with them, and, in particular, if the missing at random (MAR) assumption is valid or missing not at random (MNAR) mechanisms should be assumed. In this paper we investigated this issue through a sensitivity analysis within the ACTION study, a multicenter cluster randomized controlled trial testing advance care planning in patients with advanced lung or colorectal cancer. Methods: Multiple imputation procedures under MAR and MNAR assumptions were implemented. Possible violation of the MAR assumption was addressed with reference to variables measuring quality of life and symptoms. The MNAR mode...
Missing information is a major drawback in analyzing data collected in many routine health care sett...
This paper discusses methods of identifying the types of missingness in quality of life (QOL) data i...
The occurrence of missing data due to protocol deviations is inevitable in clinical trials. When mis...
Background: Missing data are common in end-of-life care studies, but there is still relatively littl...
BACKGROUND: Within epidemiological and clinical research, missing data are a common issue and often ...
Medical Research Council Clinical Trails Unit at UCL [Studentship to MS; MC EX G0800814 to JRC,TPM]
Acknowledgements We thank the patients who took part in the RECORD study, without whose help this st...
In observational studies with two measurements when the measured outcome pertains to a health relate...
Missing data are ubiquitous in clinical epidemiological research. Individuals with missing data may ...
Randomized control trial is a gold standard of research studies. Randomization helps reduce bias and...
Objective: QoL data were routinely collected in a randomised controlled trial (RCT), which employed...
© 2016 Dr. Panteha Hayati RezvanBackground: Missing data commonly occur in medical research, in part...
Background: Missing data is a common statistical problem in healthcare datasets fro...
BACKGROUND: Multiple Imputation as usually implemented assumes that data are Missing At Random (MAR)...
Cost-effectiveness analyses (CEA) of randomised controlled trials are a key source of information fo...
Missing information is a major drawback in analyzing data collected in many routine health care sett...
This paper discusses methods of identifying the types of missingness in quality of life (QOL) data i...
The occurrence of missing data due to protocol deviations is inevitable in clinical trials. When mis...
Background: Missing data are common in end-of-life care studies, but there is still relatively littl...
BACKGROUND: Within epidemiological and clinical research, missing data are a common issue and often ...
Medical Research Council Clinical Trails Unit at UCL [Studentship to MS; MC EX G0800814 to JRC,TPM]
Acknowledgements We thank the patients who took part in the RECORD study, without whose help this st...
In observational studies with two measurements when the measured outcome pertains to a health relate...
Missing data are ubiquitous in clinical epidemiological research. Individuals with missing data may ...
Randomized control trial is a gold standard of research studies. Randomization helps reduce bias and...
Objective: QoL data were routinely collected in a randomised controlled trial (RCT), which employed...
© 2016 Dr. Panteha Hayati RezvanBackground: Missing data commonly occur in medical research, in part...
Background: Missing data is a common statistical problem in healthcare datasets fro...
BACKGROUND: Multiple Imputation as usually implemented assumes that data are Missing At Random (MAR)...
Cost-effectiveness analyses (CEA) of randomised controlled trials are a key source of information fo...
Missing information is a major drawback in analyzing data collected in many routine health care sett...
This paper discusses methods of identifying the types of missingness in quality of life (QOL) data i...
The occurrence of missing data due to protocol deviations is inevitable in clinical trials. When mis...